![]() |
Volumn 67, Issue 5, 2016, Pages 596-598
|
Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding: Lessons From the CHAMPION PHOENIX Trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANGRELOR;
CLOPIDOGREL;
HEMOGLOBIN;
ADENOSINE PHOSPHATE;
PURINERGIC P2Y RECEPTOR ANTAGONIST;
BLEEDING;
CLINICAL TRIAL (TOPIC);
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SAFETY;
HUMAN;
LETTER;
NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME;
PERCUTANEOUS CORONARY INTERVENTION;
PRIORITY JOURNAL;
ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;
STABLE ANGINA PECTORIS;
TREATMENT OUTCOME;
ANALOGS AND DERIVATIVES;
CHEMICALLY INDUCED;
METHODOLOGY;
MYOCARDIAL INFARCTION;
PROCEDURES;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
STATISTICS AND NUMERICAL DATA;
ADENOSINE MONOPHOSPHATE;
HEMORRHAGE;
HUMANS;
MYOCARDIAL INFARCTION;
PERCUTANEOUS CORONARY INTERVENTION;
PURINERGIC P2Y RECEPTOR ANTAGONISTS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RESEARCH DESIGN;
|
EID: 84973460174
PISSN: 07351097
EISSN: 15583597
Source Type: Journal
DOI: 10.1016/j.jacc.2015.11.027 Document Type: Letter |
Times cited : (24)
|
References (5)
|